TPCW
PJP icon

TD Private Client Wealth’s Invesco Pharmaceuticals ETF PJP Stock Holding History

TD Private Client Wealth’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-500
Closed -$40.1K – 1252
2024
Q1 		$40.1K Hold
500
– – ﹤0.01% 851
2023
Q4 		$38K Buy
+500
New +$35.7K ﹤0.01% 853

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TD Private Client Wealth's PJP Position: Q2 2024 in Review

TD Private Client Wealth sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2024, closing a stake of 500 shares — an estimated $40.1K sold.

TD Private Client Wealth first reported a position in PJP in Q4 2023 and held it in 2 quarters. The position peaked at $40.1K in Q1 2024. 89 funds tracked by Wall St. Rank hold PJP as of Q2 2024.

  • TD Private Client Wealth reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
  • TD Private Client Wealth sold 500 Invesco Pharmaceuticals ETF shares in Q2 2024, an estimated $40.1K.
  • TD Private Client Wealth first reported a position in Invesco Pharmaceuticals ETF in Q4 2023 and held it in 2 quarters.
  • TD Private Client Wealth's Invesco Pharmaceuticals ETF position peaked at $40.1K in Q1 2024.
  • 89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2024.

Based on TD Private Client Wealth's 13F filing for Q2 2024, filed 14 Aug 2024.